| Company Name: |
3B Pharmachem (Wuhan) International Co.,Ltd.
|
| Tel: |
821-50328103-801 18930552037 |
| Email: |
3bsc@sina.com |
| Products Intro: |
Product Name:ZaMifenacin fuMarate;(3R)-1-[2-(1-,3-Benzodioxol-5-yl)ethyl]-3-(diphenylMethoxy)piperidinefuMarate
CAS:127308-98-9
Purity:99% HPLC Package:1Mg ; 5Mg;10Mg ;100Mg;250Mg ;500Mg ;1g;2.5g ;5g ;10g
|
| Company Name: |
BOC Sciences
|
| Tel: |
1-631-485-4226; 16314854226 |
| Email: |
info@bocsci.com |
| Products Intro: |
Product Name:Zamifenacin fumarate
CAS:127308-98-9
Purity:99% by HPLC Remarks:Zamifenacin fumarate is a selective M3 muscarinic receptor antagonist (pKi = 8.52, 7.93, 7.90 and 7.78 for M3, M2, M1 and M4 receptors, respectively). Zamifenacin fumarate exhibits higher affinity for
|
| Company Name: |
EMMX Biotechnology LLC
|
| Tel: |
888-539-0666 |
| Email: |
info@emmx.com |
| Products Intro: |
Product Name:Zamifenacin fumarate
CAS:127308-98-9
Purity:98% HPLC Package:5mg;10mg;25mg;50mg;100mg;250mg;500mg;1g
|
|
| | Zamifenacinfumarate Basic information |
| Product Name: | Zamifenacinfumarate | | Synonyms: | Zamifenacinfumarate;(3R)-1-[2-(1-,3-Benzodioxol-5-yl)ethyl]-3-(diphenylmethoxy)piperidinefumarate;UK-76654 fumarate;(R)-3-(Benzhydryloxy)-1-(2-(benzo[d][1,3]dioxol-5-yl)ethyl)piperidine fumarate;gut,UK 76654,bowel,inhibit,Inhibitor,Muscarinic acetylcholine receptor,UK-76654,muscarinic,mAChR,motility,syndrome,irritable,Zamifenacin fumarate,Zamifenacin,UK76654,colonic | | CAS: | 127308-98-9 | | MF: | C31H33NO7 | | MW: | 531.61 | | EINECS: | | | Product Categories: | | | Mol File: | 127308-98-9.mol |  |
| | Zamifenacinfumarate Chemical Properties |
| storage temp. | Inert atmosphere,2-8°C | | solubility | Soluble to 100 mM in DMSO and to 25 mM in ethanol | | form | Powder | | color | White to off-white |
| | Zamifenacinfumarate Usage And Synthesis |
| Uses | Zamifenacin Fumarate is a selective antagonist of mAChR M3 (M3 muscarinic receptor). | | Biological Activity | Selective M 3 muscarinic receptor antagonist (pK i values are 8.52, 7.93, 7.90 and 7.78 for M 3 , M 2 , M 1 and M 4 receptors respectively). Displays higher affinity at ileal M 3 receptors (pK i = 9.3) compared to oesophageal and tracheal M 3 receptors (pK i values are 8.8 and 8.2 respectively). In vivo, inhibits gastrointestinal motility in the absence of cardiovascular effects. |
| | Zamifenacinfumarate Preparation Products And Raw materials |
|